Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection. Intercept’s CEO ...
Delayed onset of canonical babbling and first words is often reported in infants later diagnosed with autism spectrum disorder (ASD). Identifying the neural mechanisms underlying language acquisition ...